Clinical trial
A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)
NCT05442775 is registered in ClinicalTrials.gov with Cytokinetics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)
- Lead sponsor
- Cytokinetics
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 4, 2022
- Completion date
- June 7, 2023
- Enrollment
- 71 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.